TFF Pharmaceuticals Inc (TFFP)
1.68
+0.11
(+7.01%)
USD |
NASDAQ |
Jun 28, 16:00
1.67
-0.01
(-0.60%)
After-Hours: 20:00
TFF Pharmaceuticals Free Cash Flow: -14.82M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -14.82M |
| December 31, 2023 | -16.13M |
| September 30, 2023 | -19.72M |
| June 30, 2023 | -24.86M |
| March 31, 2023 | -25.88M |
| December 31, 2022 | -28.89M |
| September 30, 2022 | -32.06M |
| June 30, 2022 | -31.24M |
| March 31, 2022 | -31.74M |
| Date | Value |
|---|---|
| December 31, 2021 | -30.43M |
| September 30, 2021 | -26.46M |
| June 30, 2021 | -23.67M |
| March 31, 2021 | -19.85M |
| December 31, 2020 | -16.62M |
| September 30, 2020 | -14.69M |
| June 30, 2020 | -13.51M |
| March 31, 2020 | -11.45M |
| December 31, 2019 | -11.22M |
Free Cash Flow Range, Past 5 Years
-32.06M
Minimum
Sep 2022
-11.22M
Maximum
Dec 2019
-21.85M
Average
-21.76M
Median
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
| Oragenics Inc | -8.246M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.144M |
| Cash from Financing (Quarterly) | 0.9011M |
| Free Cash Flow Per Share (Quarterly) | -1.317 |
| Free Cash Flow to Equity (Quarterly) | -3.144M |
| Free Cash Flow Yield | -435.2% |